- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Nicole Rosendale: Data Lagging in Neurologic Care for LGBTQ+ Individuals
Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist, discusses how many unknowns prevail in data concerning neurologic care for LGBTQ+ individuals.
Multiple unknowns are still present in data among LGBTQ+ individuals seeking neurologic care, says Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist.
Transcript
What are some of the greatest health-related neurological needs in the LGBTQ+ community?
I think this is a really important question and one where, unfortunately, we don't have a great answer at this point in time. There's certainly a lot more research that needs to be done. The challenge right now is that because data sources are so limited, not everyone is asking folks their sexual orientation or gender identity in a systematic way. There's a lot that we don't know. I was able to do a scoping review that was published in 2021 that tried to summarize a little bit of the current science of LGBTQ health in neurology, and there was a suggestion that there are certain disparities, particularly in terms of prevalence of certain conditions, such as stroke, for example, and conditions such as functional neurologic disorders, potentially, but there's many, many answers that we don't know and many areas of neurology that still need coverage.
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
